Astrazeneca Share Discussion Threads

[essentialinvestor] 11/3/2021 14:46

Vaccine news makes 0 difference to the AZN P&L.

AZN is trading Below the pre Covid-19 level.

It may impact sentiment, that's about it.

[beckers2008] 11/3/2021 14:43

P,

That's great news, more for the UK with their 20m + successful trial!
Now maybe Italy may release the 250k bound for Australia as it seems the EU are collectively banning the zero profit vaccine?
Makes you wonder what all the fuss was about deflecting from the fact that the EU ordered 3 months late!

[philanderer] 11/3/2021 14:29

FWIW

Iceland, Norway and Italy have now joned Denmark and Austria suspending Astra/Oxford vaccine.

[beckers2008] 11/3/2021 12:28

Montie,
Still mocking AZN 'those boys who brought at 9200?

[montyhedge] 11/3/2021 12:21

6250p my target for Astra, when the merger takes place.

[essentialinvestor] 11/3/2021 12:19

monty, not going to see the low 60's here,
without a significant wider equity sell off,
in which case about everything goes lower.

[beckers2008] 11/3/2021 12:18

Montie,
Still mocking AZN 'those boys who brought at 9200'?

[montyhedge] 11/3/2021 12:11

Will support 7000p level hold, don't think so.

[games] 11/3/2021 11:45

beckers,

i'm not sure if we would know or not in the uk.

The yellow card reporting lacks detail.

Bit like the Gov to be honest

[beckers2008] 11/3/2021 11:35

And not one blood clot problem with over 20 million people vaccinated in the UK! Really Denmark!
Currently for the sake of mankind and with so many different vaccines on the market for the EU to distribute, AZN should announce after contractual obligation fulfilment all vaccines to the EU will cease. Then watch the share price soar by 20%!

[games] 11/3/2021 11:22

Link, you will need to translate to english

[games] 11/3/2021 11:20

The above relates to Denmark

[games] 11/3/2021 11:19

Vaccination with the COVID-19 vaccine from AstraZeneca is suspended until further notice
This happens after reports of severe cases of blood clots in people who have been vaccinated with the COVID-19 vaccine from AstraZeneca. Against this background, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. At present, it cannot be concluded whether there is a link between the vaccine and the blood clots.
11 MAR 2021
Based on the concerns raised by the drug authorities, the Danish Health and Medicines Authority has, based on a precautionary principle, chosen to pause vaccination with the COVID-19 vaccine from AstraZeneca. The break lasts so far for 14 days, and the Danish Health and Medicines Authority, together with the Danish Medicines Agency, will make a new assessment in week 12.

“We are in the middle of the largest and most important vaccination rollout in Danish history. And right now we need all the vaccines we can get. Therefore, putting one of the vaccines on pause is not an easy decision. But precisely because we vaccinate so many, we also need to respond with timely care when there is knowledge of possible serious side effects. We need to clarify this before we can continue to use the vaccine from AstraZeneca, ”says Søren Brostrøm, director of the National Board of Health.

The Danish and European pharmaceutical authorities are keeping a close eye on the roll-out of vaccines against COVID-19, both in terms of the more common mild side effects and the rare, but serious, possible side effects.

As a starting point, the health authorities consider that it is unacceptable to have very serious side effects in connection with a preventive treatment, such as vaccination. Therefore, we respond early if there is the slightest sign of a possible risk with the vaccine.

"It is important to emphasize that we have not opted out of the AstraZeneca vaccine, but that we are putting it on hold. There is good evidence that the vaccine is both safe and effective. But both we and the Danish Medicines Agency have to react to reports of possible serious side effects, both from Denmark and other European countries. It shows that the monitoring system works. ”

“At the same time, it is important for us that the citizens are confident in the offer we give them and trust that we can vouch for the quality of the vaccines we have in our program. Therefore, we react promptly until we have investigated whether there is a connection between the vaccine and the possible side effects ”.

The National Board of Health is now waiting for the EU drug authorities to investigate the possible connection between the COVID-19 vaccine from AstraZeneca and the serious cases of blood clots that have been reported.

Pause means changes in the vaccine schedule
The break means that so far no one who has time for the first vaccination with the AstraZeneca vaccine will be vaccinated. It also means that those who have already got the 1st plug and are waiting for the 2nd plug, will have to wait with this for the time being.

"We have come a long way in vaccinating the frontline staff in group 4, but we are not there. I am very sorry that we now have to tell the staff who have already received the first plug, or who have already been booked or invited to the first plug, that they unfortunately have to wait until later in the spring or early summer before can be fully vaccinated ”.

"But we still need to offer vaccines to almost 1 million elderly people between the ages of 65 and 84, and we have to prioritize hard so that they get the other two vaccines we have now. We must protect the very weakest if we are to get another major outbreak of the epidemic. We must also make sure that the health service and elderly care do not break down, but our assessment is that we have already vaccinated so many frontline staff that we can handle it, ”says Søren Brostrøm.

All booked times and invitations for vaccination with the vaccine from AstraZeneca are canceled. Later, new times can be booked via vacciner.dk.

Booked appointments for vaccination with one of the other vaccines from Pfizer and Moderna, respectively, do not change. Frontline staff aged 65 or over will continue to receive vaccination offers with one of the other two vaccines.

A new version of the vaccination plan has been made, in which AstraZeneca has been completely removed, to illustrate a worst-case scenario. It shows that everyone in Denmark who is 16 years or older can only have been offered vaccination by week 28 (the second week of July), and that everyone can be fully vaccinated approx. 4 weeks later. But it is important to emphasize that the vaccination plan will look better if we resume the use of AstraZeneca at the reassessment in week 12.

[ianb5004] 11/3/2021 11:01

22 cases in 3 million vaccines looks low - - The figures of NATURAL occurrence are 1 in a 1000 adults over age 45.
So 3000 in a million is the natural annual occurrence - if you vaccinate 3 million some will get a thrombosis as they were going to anyway.

[triple witcher] 11/3/2021 10:38

Further to my post yesterday about a down day today bought at 7009 for another short term trade.4 hourly chart signified overbought in the shorter term, pull backs are healthy for consolidation

[montyhedge] 11/3/2021 10:37

One thing COVID vaccine makers are immune from class actions if it went wrong, that's my understanding.

[soho2] 11/3/2021 10:28

And the blood clot "fear" is certainly not helping sentiment here !

[montyhedge] 11/3/2021 09:51

Big support level at 7000p, interesting to see if it holds.

[mcbull] 11/3/2021 08:11

Batch ABV5300 was delivered to 17 EU countries1 and comprises 1 million doses of the vaccine. Some EU countries2 have also subsequently suspended this batch as a precautionary measure, while a full investigation is ongoing. Although a quality defect is considered unlikely at this stage, the batch quality is being investigated.

EMA’s safety committee PRAC is reviewing this issue; it is investigating the cases reported with the batch as well as all other cases of thromboembolic events, and other conditions related to blood clots, reported post-vaccination. The information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population.

As of 9 March 2021, 22 cases of thromboembolic events had been reported among the 3 million people vaccinated with COVID-19 Vaccine AstraZeneca in the European Economic Area.

[buywell3] 11/3/2021 02:20

It has been reported that 5 countries have halted astrazeneca vavccine jabs from a batch labelled ABV5300 which comprised one million doses and has been delivered to 17 EU countries

[philanderer] 10/3/2021 20:01

(Alliance News) - Europe's medicines watchdog said Wednesday a preliminary probe showed that a batch of AstraZeneca PLC vaccines used in Austria was not to blame for the death of a nurse who received a jab.

"There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the European Medicines Agency said in a statement, also referring to another nurse who was hospitalised after being vaccinated.